Prognostic value of loss of heterozygosity and KRAS2 mutations in lung adenocarcinoma

International Journal of Cancer

Volumn 79, Issue 3, 1998, Pages 269-272

  De Gregorio, Laura ^a   Manenti, Giacomo ^a   Incarbone, Matteo ^b   Pilotti, Silvana ^a   Pastorino, Ugo ^b   Pierotti, Marco A ^a   Dragani, Tommaso A ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Division of Thoracic Surgery   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED STUDY; GENE LOCUS; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MARKER GENE; PRIORITY JOURNAL; PROGNOSIS; SMOKING; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; GENES, RAS; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MUTATION; PROGNOSIS;

EID: 0031776498     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980619)79:3<269::AID-IJC10>3.0.CO;2-3     Document Type: Article

References (21)

1. FlNKELSTEIN, S.D., SAYEGH, R., CHRISTENSEN, S. and SWALSKY, P., Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type. Cancer, 71, 3827-3838 (1993).
2. FONG, K.M., KIDA, Y., ZIMMERMAN, P.V., IKENAGA, M. and SMITH, P.J., LOSS of heterozygosity frequently affects chromosome 17q in non-small cell lung cancer. Cancer Res., 55, 4268-4272 (1995a).
3. FONG, K.M., ZIMMERMAN, P.V. and SMITH, P.J., Tumor progression and loss of heterozygosity at 5q and 18q in non-small cell lung cancer. Cancer Res., 55, 220-223 (1995b).
4. FUJIWARA, Y., OHATA, H., EMI, M., OKUI, K., KOYAMA, K., TSUCHIYA, E., NAKAJIAMA, T., MONDEM, M., MORI, T., KURIMASA, A., OSHIMURA, M. and NAKAMURA, Y., A 3-Mb physical map of the chromosome region 8p21.3-p22. including a 600-kb region commonly deleted in human hepatocellular carcinoma, colorectal cancer, and non-small cell lung cancer. Genes Chromosomes Cancer, 10, 7-14 (1994).
5. FUKUYAMA, Y., MITSUDOMI, T., SUGIO, K., ISHIDA, T., AKAZAWA, K. and SUGIMACHI, K., K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer. Brit. J. Cancer, 75, 1125-1130 (1997).
6. HORIO, Y., TAKAHASHI, T., KUROISHI, T., HIBI, K., SUYAMA, M., NIIMI, T., SHIMOKATA, K., YAMAKAWA, K., NAKAMURA, Y. and UEDA, R. Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer. Cancer Res., 53, 1-4 (1993).
7. KISHIMOTO, Y., SUGIO, K., MITSUDOMI, T., OYAMA, T., VIRMANI, A.K., MCINTIRE, D.D. and GAZDAR, A.F., Frequent loss of the short arm of chromosome 9 in resected non-small-cell lung cancers from Japanese patients and its association with squamous cell carcinoma. J. Cancer Res. Clin. Oncol., 121, 291-296 (1995).
8. MANENTI, G., PILOTTI, S., RE, F.C., DELLA PORTA, G. and PIEROTTI, M.A., Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas. Europ. J. Cancer, 30A, 987-993 (1994).
9. MERLO, A., GABRIELSON, E., ASKIN, F. and SIDRANSKY, D., Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res., 54, 640-642 (1994).
10. OHATA, H., EMI, M., FUJIWARA, Y., HIGASHINO, K., NAKAGAWA, K., FUTAGAMI, R., TSUCHIYA, E. and NAKAMURA, Y., Deletion mapping of the short arm of chromosome 8 in non-small cell lung carcinoma. Genes Chromosomes Cancer, 7, 85-88 (1993).
11. OLOPADE, O.I., BUCHHAGEN, D.L., MALIK, K., SHERMAN, J., NOBORI, T., BADER, S., NAU, M.M., GAZDAR, A.F., MINNA, J.D. and DIAZ, M.O., Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers. Cancer Res., 53, 2410-2415 (1993).
12. PETO, R., PIKE, M.C., ARMITAGE, P., BRESLOW, N.E., Cox, D.R., HOWARD, S.V., MANTEL, N., MCPHERSON, K., PETO, J. and SMITH, P.G., Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Brit. J. Cancer, 35, 1-39 (1976).
13. RODENHUIS, S., SLEBOS, R.J.C., BOOT, A.J.M., EVERS, S.G., MOOI, W.J., WAGENAAR, S.S., VAN BODEGOM, P.C. and BOS, J.L., Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the lung. Cancer Res., 48, 5738-5741 (1988).
14. ROSELL, R., MONZÓ, M., PIFARRÉ, A., ARIZA, A., SANCHEZ, J.J., MORENO, I., MAUREL, J., PAZ LOPEZ, M., ABAD, A. and MARIA DE ANTA, J., Molecular staging of non-small cell lung cancer according to K-ras genotype. Clin. Cancer Res., 2, 1083-1086 (1996).
15. SATO, S., NAKAMURA, Y. and TSUCHIYA, E., Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res., 54, 5652-5655 (1994).
16. SIMONEAU, A.R., SPRUCK III, C.H., GONZALES-ZULUETA, M., GONZALGO, M.L., CHAN, M.F., TSAI, Y.C., DEAN, M., STEVEN, K., HORN, T. and JONES, P.A., Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations. Cancer Res., 56, 5039-5043 (1996).
17. SLEBOS, R.J.C., KIBBELAAR, R.E., DALESIO, O., KOOISTRA, A., STAM, J., NEIFIER, C.J.L.M., WAGENAAR, S.S., VAN DER SCHUEREN, R., VAN ZANDWIJK, N., MOOI, W.J., BOS, J.L. and RODENHUIS, S., K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N. Engl. J. Med., 323, 561-565 (1990).
18. SOZZI, G., MIOZZO, M., PASTORINO, U., PILOTTI, S., DONGHI, R., GIAROLA, M., DE GREGORIO, L., MANENTI, G., RADICE, P., MINOLETTI, F., DELLA PORTA, G. and PIEROTTI, M.A., Genetic evidence of field cancerization in patients with multiple synchronous tumors of the lung. Cancer Res., 55, 135-140 (1995).
19. SUGIO, K., ISHIDA, T., YOKOYAMA, H., INOUE, K., SUGIMACHI, K. and SASAZUKI, T., ras Gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis. Cancer Res., 52, 2903-2906 (1992).
20. TAKEUCHI, S., MORI, K., KOIKE, M., SLATER, J., PARK, S., MILLER, C.W., MIYOSHI, J. and KOEFFLER, H.P., Frequent loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: evidence for a new tumor suppressor gene on the short arm of chromosome 12. Cancer Res., 56, 738-740 (1996).
21. THIBERVILLE, L., BOURGUIGNON, J., METAYER, J., BOST, F., DIARRA-MEHRPOUR, M., BIGNON, J., LAM, S., MARTIN, J.P. and NOUVET, G., Frequency and prognostic evaluation of 3p21-22 allelic losses in non-small-cell lung cancer. Int. J. Cancer, 64, 371-377 (1995).